Evaluation of the impact of a psycho-educational intervention on knowledge levels and psychological outcomes for people diagnosed with Schizophrenia and their caregivers in Jordan: A randomized controlled trial by Hasan, AA et al.
Hasan et al. BMC Psychiatry 2014, 14:17
http://www.biomedcentral.com/1471-244X/14/17STUDY PROTOCOL Open AccessEvaluation of the impact of a psycho-educational
intervention on knowledge levels and
psychological outcomes for people diagnosed
with Schizophrenia and their caregivers in Jordan:
a randomized controlled trial
Abd Alhadi Hasan*, Patrick Callaghan and Joanne S LymnAbstract
Background: Schizophrenia is one of the most serious forms of mental illness among people being treated in
psychiatric clinics in developing and developed countries. Providing care for people diagnosed with schizophrenia
can be stressful for their caregivers. Psycho-educational interventions may improve patients’ and primary caregivers’
knowledge of schizophrenia and impact positively on patients’ physical and psychological outcomes and primary
caregivers’ burden of care and quality of life. Studies thus far have shown that these interventions may improve
patients’ and caregivers’ outcomes, but the quality of included randomized controlled trials (RCTs) is poor and it is
difficult to draw firm conclusions as to the effectiveness of such interventions on patients and primary caregivers’
outcomes, hence the current study.
Methods/Design: A randomized controlled trial in four outpatient mental health clinics in Jordan comparing
psycho-educational interventions in the form of six booklets every fortnight, with treatment as usual in people diag-
nosed with schizophrenia and their primary caregivers. The primary outcome for participants is knowledge of Schizo-
phrenia; secondary outcomes for patients are positive and negative symptoms of schizophrenia and relapse rate, while
secondary outcomes for primary caregivers are burden of care and quality of life. All measures are assessed at baseline,
immediately post-intervention and at three months follow-up.
Discussion: This randomized control trial, conducted in Jordan among people living with schizophrenia and their
primary caregivers, will assess the effect of psycho-educational interventions on knowledge of Schizophrenia, patients’
positive and negative symptoms and quality of life, and caregivers’ burden of care.
Trial registration: Current Controlled Trials ISRCTN78084871
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Schizophrenia is one of the most common and serious
forms of mental illness and is often chronic, recurrent,
disabling and debilitating [1].
While studies have reported that the main cause of
schizophrenia is unknown, a widely accepted model is
the stress vulnerability hypothesis, which proposes that
the interaction between biological vulnerability and
socio-environmental stressors, including social stressors,
have a significant role in the presentation and illness
course [2]. This model suggests that schizophrenia is
caused by an imbalance in biological or psychological
systems. Imbalance in biological systems is considered
the main precipitating cause for schizophrenia, and it in-
cludes genetics, head injury and viral infection. The im-
pact of schizophrenia is commonly mitigated by taking
medication and abstaining from alcohol. The psycho-
logical system is concerned with stress; stress is caused
by events that challenge people and compel them to
adapt themselves in order to function as ‘normal’. How-
ever, people who struggle to adapt to stressful life events
(e.g. bereavement, loss of job) often report poorer dis-
ease symptoms [3].
Previous studies have estimated that schizophrenia af-
fects around 1.1% of the adult population worldwide,
which equates to around 51 million people. Commonly,
people are diagnosed with schizophrenia before the age
of 25 years [4].
The health system in Jordan has three sectors: Ministry
of Health (MoH), private and military. The MoH provides
healthcare to the majority of the Jordanian population [5].
In Jordan, a recent report [5] has shown that 305 indi-
viduals per 100,000 of the population have been diag-
nosed with mental illness, 50% of whom are diagnosed
with schizophrenia, making this a significant healthcare
issue.
Family interventions described in previous randomized
controlled trials (RCTs) [6-8] are psycho-educational in
nature and seek to improve patients and primary care-
givers’ knowledge of schizophrenia and change patients
and primary caregivers’ behaviour by improving their
knowledge about expected ‘maladaptive’ behaviour, dis-
ease symptoms and how can they deal with these issues
using psycho-educational interventions [9]. Whilst the
content psycho-educational intervention varies between
studies, there are common factors among most studies
[7,10-12] including; general information about schizo-
phrenia, symptoms, medication management, problem-
solving strategies and communication skills for patients
and primary caregivers. Psycho-educational interven-
tions are usually delivered by psychiatrists [13]. mental
health nurses [6,7,13] and social workers [14]. The aver-
age duration of sessions varies among studies from 60 to
120 minutes [7,10,15-17], The methods of deliveringpsycho-educational interventions in studies for people
diagnosed with Schizophrenic patients and primary care-
givers include lectures [7,10,18-20], face to face methods
supported with a printed booklet [10,13] and online edu-
cation [20].
Studies which adopted an online method of delivering
psycho-educational interventions to participants re-
vealed a substantial improvement in patients diagnosed
with schizophrenia and caregivers’ knowledge levels and
patients’ symptoms [8], stress and social support levels
[20]. Additionally, delivering psycho-educational inter-
ventions with minimal interaction such as printed book-
lets and online provision has shown a similar effect on
participants’ outcomes [20]. A recent meta-analysis [21]
of RCTs that delivered psycho-educational interventions
online, by email and by printed leaflets was easy to ac-
cess for large numbers of mental health patients and
their primary caregivers at a relatively low cost. There
has been an increasing interest recently demonstrating
the effectiveness of psycho-education interventions using
online, or booklets on patients and caregivers’ outcomes
in relatively resource-poor countries [21].
Studies thus far have shown that these interventions
may improve patients’ and primary caregivers’ outcomes,
but the quality of included RCTs is poor due to a lack of
randomization and blinding and insufficient sample sizes
[22]. Consequently, the evidence base is inconclusive
about the effectiveness of such interventions on patients
and primary caregivers’ outcomes, hence the current
study.
Aim
The aim of this study is to investigate the the effectiveness
of psycho-educational intervention delivered via a printed
booklet on people diagnosed with Schizophrenia and their
primary caregivers’ outcomes. It is anticipated that treat-
ment as usual and psycho-educational intervention deliv-
ered by a booklet will: Improve patients’ and primary
caregivers’ knowledge of schizophrenia, improve patients’
positive and negative symptoms and reduce their relapse
rates, and improve primary caregivers’ burden of care and
quality of life better than treatment as usual alone.
Method/design
The study is a randomized controlled trial comparing
the effect of psycho-educational intervention delivered
via a printed booklet with treatment as usual on people
diagnosed with Schizophrenia and their primary care-
givers’ outcomes assessed at baseline, immediately post-
intervention and at three months follow-up.
Setting
The study will be conducted in four state funded psychi-
atric outpatient clinics in Amman, Jordan.
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Participants will be people aged 18 years or over, diag-
nosed with schizophrenia or schizoaffective disorder,
and their primary caregivers.
Inclusion criteria
To be included in this study patients will have a primary
diagnosis of schizophrenia according to the Diagnostic
and Statistical Manual of Mental Disorders, 4th Edition
(DSM-IV) [23] and their primary caregivers. Caregivers
are defined as the primary caregiver with close contact
with the person. All participants should be able to read
and write English or Arabic and be willing and able to
consent.
Exclusion criteria
Patients will be excluded if they have a learning disabil-
ity, known organic mental disorder, have current sub-
stance abuse, living alone or without close contact with
caregivers, or who are currently receiving any formal
psycho-educational intervention. Primary caregivers will
be excluded if they are involved in caring for more than
one person with a diagnosed mental health problem.
Recruitment
People diagnosed with schizophrenia or schizoaffective
disorder in Jordan typically visits outpatient clinics with
their family member. A poster about the study will be dis-
played in these clinics advertising the study and requesting
volunteers. Interested participants will receive further in-
formation about the study directly from a research student
or mental health professional in these clinics.
The study will recruit acute or chronic patients being
treated in these clinics when they attend for appoint-
ments. AH or another mental health professional will
inform participants about the study. The study informa-
tion package will be given to each participant alongside
a verbal explanation about the project. Sufficient time
will be afforded to each participant to read the study in-
formation. Participants will be asked to return a signed
consent form to nursing department in the clinic. AH
will administer a study inclusion checklist to assess
participants’ eligibility.
Randomization
Participants who meet the inclusion criteria will be ran-
domly allocated to one of the study arms by an inde-
pendent research professional not connected to the
study The allocation of participants to the study arm will
be determined by a random number list generated by
another researcher who has had no contact or access to
recruited participants in the trial.
Randomization will be implemented by using a third
remote allocation system, PC will generate and send arandom list to the independent researcher, AH will then
contact the researcher when each participant is re-
cruited, to receive the allocation. The allocation of par-
ticipants to the study is shown in Figure 1.
Intervention
Psycho-education intervention
Besides treatment as usual, participants in the experi-
mental arm of study will receive a psycho-educational
booklets each fortnight for 12 weeks. Primary caregivers
will receive follow-up phone calls to ensure that they
have read and understood the booklet and to allow them
to ask questions about its content. The psycho-
educational intervention is based on the framework of
Atkinson and Coia [24]. The booklets were developed by
the research team and the content was checked, assessed
and approved by an independent psychiatrist uncon-
nected to the study. The booklets will be distributed to
patients or caregivers during an outpatient visit. Booklets
will be distributed inside a sealed envelope to maintain
participants’ anonymity and minimize contamination be-
tween study arm participants. The booklet contents are
shown in Table 1.
Treatment as usual (TAU)
TAU consists of medication, and laboratory investiga-
tions delivered by the mental health team.
Measures
After recruitment and obtaining written consent from
participants, but prior to randomization, baseline assess-
ments will be taken by AH. Baseline assessment includes
clinical information from the patient’s clinic record
(medical diagnosis and illness duration) and demo-
graphic information; age, education level, employment
status and marital status.
The primary outcomes for patients and primary care-
givers are knowledge about schizophrenia measured by
the Knowledge about Schizophrenia Questionnaire
(KASQ). Secondary outcomes are schizophrenia symp-
toms measured by the Positive and Negative Symptom
Scale (PANSS) for patients and Family Burden of Care
measured by the Family Burden interview Scale (FBIS)
and quality of life measured by the Schizophrenic Carers
Quality of Life Scale (S-CQoL) for caregivers.
KASQ is a self-reported questionnaire developed by
Ascher-Svanum [25]. It consists of 25 multiple-choice
items intended to measure patients’ basic knowledge
about schizophrenia and its management, aetiology,
prevalence, prognosis, treatment and anti-psychotic
medication effects and side effects. KASQ is scored
from 0 to 25 with a higher score indicating more
knowledge. KASQ has been used with people diag-
nosed with Schizophrenia and carers worldwide.
Allocated to psychoeducation intervention (n=72)
Allocated to treatment as usual (n= 72)
Allocation
AH will Recruit (n=144)
Eligibility checklist is assessed and asked to sign consent form
Baseline measures (n=144)
Randomization (n=144)
Outcomes at end of intervention (n=142, assuming 15% attrition rate in both 
study arm)
Usual care participants receive psycho-
education intervention
Figure 1 Flow diagram of study design.
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coefficients of 0.89 and 0.85 and test-retest reliability
coefficient over three weeks was 0.83.
The PANSS was developed by Kay [26]. It assesses
positive, negative and general psychopathology schizo-
phrenia symptoms. The scale measures 30 clinical symp-
toms of schizophrenia, each symptom is scored from 1
indicating absence of psychopathology to 7 indicating se-
vere psychopathology with higher scores indicating a
poorer mental health status. The scale has good internal
reliability and criterion related validity was examined with
Andreasen rating systems. The result indicated that high
correlation between two positive scales (r = 0.77, P < .0001)
and negative scales (r = 0.77, P < .0001). And GPS from
PANSS examined with Clinical Global Impression scale
(CGI) and correlation was (r = 0.52, P < .0001) [27].
The FBIS was developed by Pai and Kapur [28] and as-
sesses subjective, objective and global burden care of car-
ing for mentally ill relatives at home. The FBIS consists of
24 items and focuses on six domains of caregivers’ burden:
family finance, routine, leisure time, physical health, men-
tal health and family interaction. Each item is rated on a
three-point Likert scale (0: no burden, 1: moderate bur-
den, 2: severe burden). The participants’ final scores range
from 0 to 48; a higher score indicates a higher level of bur-
den. The scale has good reliability and validity (Cronbach’s
alpha 0.87; test-retest 0.83) [29].
The S-CQoL was developed by Richieri [30] to assess
the impact of caring for people diagnosed withSchizophrenia on carers’ quality of life. The S-CQoL
consists of 25 items scored from 25 to 125; a higher
score indicates a good quality of life. The S-CQoL has
seven dimensions: Physical and Psychological Wellbeing
(PsPhW), Psychological Burden and Daily Life (PsBDL),
Relationships with Spouse (RS), Relationships with
Psychiatric Team (RPT), Relationship with Family (RFa),
Relationships with friends (RFr) and Material Burden
(MB). The Scale has an adequate internal consistency for
all dimensions ranging from 0.64 to 0.95 and Cronbach’s
alpha is 0.79 to 0.92. External validity examination was
shown a significantly correlated S-QoL dimension with all
short form-36 dimension scores (SF-36) [30].
In reviewed literature, there were disparities in the oper-
ational definition of relapse. However, the majority of
these studies adopted numbers of readmission, or exacer-
bations in psychotic symptoms of more than 5–10 points
measured on the Brief Psychiatric Rating Scale (BPRS) or
PANSS, the number of increases in anti-psychotic medica-
tion dosage, or medication compliance. For this study, re-
lapse is defined as the number of readmissions measured
at baseline three months prior to the study commencing,
at end of intervention immediately and three months fol-
low up. Furthermore, relapse with medication means the
numbers of increasing current antipsychotic medications
prescribed to patients during the same intervals. These
data will be obtained from participants’ medical records.
None of these outcomes have been used in an Arabic
speaking country so they will be translated from English
Table 1 Component of the psycho-educational intervention
Booklet number Contents
One -What is schizophrenia?-Common myths about schizophrenia.
-Prevalence.
-Disorder course.
-Positive and negative symptoms of schizophrenia.
-How is the schizophrenia diagnosed?
Two -Stress vulnerability Model of psychiatric disorder.
-Psychobiological vulnerability to disorders (genetic and biological factors).
-Effects of alcohol and drug abuse and medication on symptoms.
-How family members can help.
Three -Medication effects on disorder (Treatment of acute symptoms).
-The pros and cons of long term medication.
-Strategies for managing side effects.
Four -Early warning sign of relapse.
-Definition.
-Common early warning signs.
-Identification of early warning signs for the client.
-Explanation concept burden of care, importance of self-care and understanding the patients’ needs for help.
Five -Recommendation for improving coexistence in the family.
-Understand common difficulties.
-Understand the concept of listening and empathy.
-Problem solving strategies.
-Managing disruptive behaviours.
Six -Family expectation from patients and patients’ expectation from family.
-Creating a low stress environment and ways to reduce stress.
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any discrepancies by independent bilingual translator
and original author for each instrument to maintain
content validity. Prior to the main study, we will recruit
two patients and two carers to test participants’ accept-
ability and understanding of the scales.
All measures will be assessed at baseline, immediately
post-intervention and at 3 month follow-up.Blinding
Participants will be aware of which group, to which they
have been allocated. In addition, the researchers are also
aware of participants’ allocation. In order to minimize
potential bias AH will assess baseline measures prior to
allocation; post intervention and follow-up measures will
be assessed by an independent researcher unaware of
the participants’ allocation.Sample size
We are seeking to detect a mean KASQ improvement
two scores (8%) in the intervention arm and have esti-
mated that with a power of 80% and significance level ofp < 0.05, allowing for 15% attrition, deduced from previ-
ous studies, 144 participants will be required.
Data analysis
The first stage of the quantitative data analysis will de-
scribe participants’ responses to the continuous vari-
ables, i.e. KASQ, PANSS, FBIS and S-CQOL scores and
patients’ total and mean relapse rates. The next stage of
the data analysis will compare KASQ, PANSS, FBIS and
S-CQOL scores, and patient relapse rates between the
intervention and control arms using independent sample
t tests, or non-parametric equivalents if the data are not
normally distributed. Effect sizes, 95% confidence inter-
vals (CI), Numbers needed to treat (NNT) and odds ra-
tios will be reported. The third stage of the data analysis
will use regression analyses to identify which of the base-
line measures are statistically significant predictors of
post intervention and follow-up outcomes. The final
stage of the data analysis will investigate pre and post
intervention differences on all measures within the inter-
vention and control arms using a related t test or non-
parametric equivalent if the data are not normally
distributed. The level of significance for all analyses will be
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tical Package for the Social Sciences (SPSS) version 21.
Ethical approval
Ethical approval has been obtained from University of
Nottingham Faculty of Medicine and Health Sciences
Research Ethics Committee (SNMP 12072012) and the
Scientific Research Ethics Committee from Ministry of
Health, Jordan (Ref 9067). The trial has been registered
with Current Controlled Trials, registration number
ISRCTN78084871.
Discussion
Findings from this trial will show the effect of psycho-
education delivered via printed booklets, and treatment as
usual on outcomes for people diagnosed with Schizophrenia
and their primary caregivers when compared with treat-
ment as usual alone.
Trial status
The trial commenced recruitment in September 2012.
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